HemaSphere (Aug 2023)

PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYMPHOMA

  • Jason Westin,
  • Caron Jacobson,
  • Julio C Chavez,
  • Anna Sureda,
  • Franck Morschhauser,
  • Bertram Glass,
  • Michael Dickinson,
  • Andrew J. Davies,
  • Ian W. Flinn,
  • David Maloney,
  • Martine Chamuleau,
  • Michael Tees,
  • Allen Xue,
  • Shilpa Shahani,
  • Olga Nikolajeva,
  • Janet Kang,
  • Aida Kaplan,
  • Marco Schupp,
  • Harry Miao,
  • Elizabeth Shima Rich

DOI
https://doi.org/10.1097/01.HS9.0000975996.32786.92
Journal volume & issue
Vol. 7
p. e3278692

Abstract

Read online

No abstracts available.